1. Introduction {#s0005}
===============

The root bark of *Lycium chinense* Mill. or *Lycium barbarum* L., named Digupi in China, is a famous traditional Chinese medicine. During the recent decades, it has been used for treating diabetes, cough, hypertension, and fever. Previous phytochemical investigations have been reported for different types of chemical constituents, including alkaloids, cyclopeptides, lignans, anthraquinones, coumarines, flavonoids, terpenoids, sterols, and other compounds[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13]. As part of an ongoing effort for bioactive constituents from the root bark of *L. chinense*, two new compounds (lyciumlignan D and lyciumphenyl propanoid A, [Fig. 1](#f0005){ref-type="fig"}) and seven known compounds (**3**--**9**) were isolated. In addition, all of the isolates were tested for anti-inflammatory activity by suppressing the production of NO in lipopolysaccharide-induced BV2 cells. In this paper, we reported the isolation, structure elucidation, and bioactivity evaluation of the compounds isolated from the root bark of *L. chinense.*Figure 1Structures of compounds **1**--**9**.Fig. 1

2. Results and discussion {#s0010}
=========================

Compound **1** was obtained as a white amorphous powder, whose molecular formula was confirmed to be C~27~H~36~O~14~ by the sodiated molecular ion peak observed at *m*/*z* 607.2000 \[M + Na\]^+^ in the HR-ESI-MS. In the IR spectrum, absorption bands for hydroxyl group (3382 cm^--1^), chemical bond \--CH~2~\-- (2929 cm^--1^), and aromatic ring (1616, 1518, and 1463 cm^--1^) were observed. The ^1^H NMR spectrum ([Table 1](#t0005){ref-type="table"}) displayed four aromatic proton signals at *δ*~H~ 6.63 (2 H, s), 6.87 (1 H, d, *J* =1.5 Hz), and 6.86 (1 H, d, *J*=1.5 Hz), revealing the presence of two tetra-substituted aromatic rings. In the upfield region, four oxymethylene protons at *δ*~H~ 3.67 (1 H, m), 3.60 (1 H, m), 3.35 (1 H, m), and 3.16 (1 H, m), three oxymethine protons at *δ*~H~ 5.39 (1 H, d, *J*=7.0 Hz), 4.55 (1 H, d, *J*=6.0 Hz), and 3.63 (1 H, m), and one methine proton at *δ*~H~ 3.46 (1 H, m) were detected. In addition, three methoxyl groups at *δ*~H~ 3.72 (6 H, s) and 3.76 (3 H, s) and a glucopyranosyl anomeric proton at *δ*~H~ 4.39 (1 H, d, *J* = 7.5 Hz) were observed. The ^13^C NMR spectrum ([Table 1](#t0005){ref-type="table"}) of **1** exhibited 27 carbon signals, apart from three methoxyl groups and six carbon signals of one *O*-glucose unit, and the remaining 18 carbon signals could be attributed to a lignan skeleton[@bib4], [@bib14]. The HMBC correlations ([Fig. 2](#f0010){ref-type="fig"}) from H-7 (*δ*~H~ 5.39) to C-1, C-2, C-6, C-8, and C-9, and from H-7′ (*δ*~H~ 4.55) to C-1′, C-2′, C-6′, C-8′ and C-9′ confirmed the presence of two C6-C3 units. Furthermore, the key correlations from H-8 (*δ*~H~ 3.46) to C-4′, C-5′, and C-6′, and from H-7 (*δ*~H~ 4.55) to C-4′ and C-5′ verified that **1** was a benzofuran-type lignan. The locations of three methoxyl groups were determined to be at C-3, C-5, and C-3′ by the HMBC correlations of *δ*~H~ 3.72, 3.72, 3.76 with C-3, C-5, C-3′, respectively. Based on the HMBC correlation of the anomeric proton H-1′′ correlated with C-7′, the glucose unit was determined to be located at C-7′. The *trans* configuration between H-7 and H-8 was identified by a big coupling constant (*J*~7,8~=7.0 Hz). In combination with positive Cotton effect at 243 and 286 nm, the 7 *S*,8 *R* configurations of **1** was established[@bib14]. Furthermore, the 7′,8′-*threo* configuration was confirmed by the coupling constant of H-7′ (*J*~7,8~ = 6.0 Hz). Unfortunately, the absolute configurations of C-7′ and C-8′ were not identified. From the above analysis, the structure of **1** was elucidated as shown, and was accorded the trivial name lyciumlignan D.Figure 2Key HMBC (H→C) correlations of compounds **1** and **2**.Fig. 2Table 1^1^H NMR (500 MHz) and ^13^C NMR (125 MHz) spectral data of compounds **1** and **2** in DMSO-*d*~6~ (*δ* in ppm, *J* in Hz).Table 1Position**12***δ*~H~*δ*~C~*δ*~H~*δ*~C~1131.3130.626.63, s103.77.03, d (1.5)109.93147.9149.84135.3146.65147.97.00, d (8.0)115.866.63, s103.76.88, dd (1.5, 8.0)11975.39, d (7.0)87.36.45, d (16.0)128.583.46, m536.25, dt (16.0, 5.0)128.893.67, m62.74.08, brd (5.0)61.63.60, m103.84, m683.68, m114.34, m78.8123.58, m601′133.54.19, d (8.0)103.32′6.87, d (1.5)115.72.95, t (8.5)73.33′142.93.13, m76.64′146.63.00, t (9.0)705′128.73.24, m75.46′6.86, d (1.5)112.23.41, m67.57′4.55, d (6.0)828′3.63, m75.29′3.35, m61.93.16, m1′′4.39, d (7.5)104.24.83, d (2.5)109.22′′3.06, m74.23.75, m75.83′′3.02, m76.978.84′′3.04, m69.93.56, m73.33.76, m5′′3.14, m76.43.32, m63.26′′3.57, m613.33, m3-CH~3~O3.72 (s)563.76, s55.55-CH~3~O3.72 (s)563′′-CH~3~O3.76 (s)55.7

Compound **2** was isolated as a white amorphous powder. Its molecular formula (C~24~H~36~O~14~) was deduced from positive HR-ESI-MS (*m*/*z* 571.2007 \[M + Na\]^+^). The IR spectrum similarly revealed the existence of hydroxyl, \--CH~2~\--, and aromatic ring. In the ^1^H NMR spectrum ([Table 1](#t0005){ref-type="table"}), a set of ABX spin-system aromatic protons at *δ*~H~ 7.03 (1 H, d, *J*=1.5 Hz), 7.00 (1 H, d, *J*=8.0 Hz), and 6.88 (1 H, dd, *J*=1.5, 8.0 Hz), a set of typical *trans*- double bond resonances at *δ*~H~ 6.45 (1 H, d, *J*=16.0 Hz) and 6.25 (1 H, dt, *J*=16.0, 5.0 Hz), two oxymethylene protons at *δ*~H~ 4.08 (2 H, brd, *J*=5.0 Hz), and a methoxy group at *δ*~H~ 3.76 (3 H, s) were displayed, which indicated the presence of a coniferyl alcohol unit. Additionally, four oxymethylene protons at *δ*~H~ 3.84 (1 H, m), 3.68 (1 H, m), and 3.58 (2 H, m), together with an oxymethine proton at *δ*~H~ 4.34 (1 H, m) confirmed the existence of a glycerol moiety. Two anomeric protons at *δ*~H~ 4.19 (1 H, d, *J*=8.0 Hz) and 4.83 (1 H, d, *J*=2.5 Hz) were also observed in the upfield region, which could be assigned to a glucose moiety and an apiose moiety[@bib4]. The ^13^C NMR spectrum ([Table 1](#t0005){ref-type="table"}) of **2** exhibited 24 carbon signals, including a coniferyl alcohol moiety, a glycerol moiety, a glucose moiety, and an apiose moiety. The connections between these moieties were established by the HMBC correlation peaks ([Fig. 2](#f0010){ref-type="fig"}). An obvious HMBC correlation from H-11 (*δ*~H~ 4.34) to C-4 (*δ*~C~ 146.6) indicating the C~11~-O-C~4~ connection between coniferyl alcohol and glycerol moiety. Moreover, the HMBC correlation of H-1′ (*δ*~H~ 4.19) with C-10 (*δ*~C~ 68.0) revealed that the glucopyranose unit was attached to C-10, while the correlation of H-1′′ (*δ*~H~ 4.83) with C-6′ (*δ*~C~ 67.5) suggested that the apiofuranose unit was attached to C-6′. Consequently, the structure of **2** was identified as shown, and was accorded the trivial name lyciumphenylpropanoid A.

The structures of seven known compounds (**3**---**9**) isolated from the root bark of *L. chinense*, were also identified by comparison of their spectroscopic data to those found in the literature. They were elucidated as: periplocoside M (**3**)[@bib15], intrapilosin I (**4**)[@bib16], (--)-lyoniresinol-4,9′-di-*O*-*β*-[d]{.smallcaps}-glucopyranoside (**5**)[@bib17], cedrusin (**6**)[@bib18], smiglabrol (**7**)[@bib19], 2′,5-dihydroxy-6,7,8,6′-tetramethoxy flavone (**8**) [@bib20] and lycifuranone A (**9**)[@bib21].

All of the compounds were tested for their anti-inflammatory activities by suppressing the production of NO in lipopolysaccharide-induced BV2 cells. As a result, compounds **3**, **6**, and **7** exhibited 87.5%, 83.6%, and 75.0% inhibition at 10 μmol/L, respectively, whereas the positive control curcumin showed 65.75% inhibition at 10 μmol/L. Then, a further test of compounds **3**, **6**, and **7** was performed at 1 μmol/L, which demonstrated 60.0%, 56.9%, and 60.0% inhibition, respectively,

3. Experimental {#s0015}
===============

3.1. General experimental procedure {#s0020}
-----------------------------------

Optical rotations were measured on a Jasco P-2000 polarimeter (Jasco Corp; Tokyo, Japan). The UV spectra were measured on a Jasco V650 spectrophotometer (Jasco). The IR spectra were recorded on a Nicolet 5700 spectrometer (Thermo Scientific, FL). The CD spectra were measured on a Jasco J-815 CD spectrometer (Jasco). High-resolution electrospray ionization mass spectrometry (HR-ESI-MS) was performed on an Agilent 6520 HPLC-Q-TOF (Agilent Technologies, Waldbronn, Germany). ^1^H NMR (500 MHz), ^13^C NMR (125 MHz), and 2D NMR spectra were recorded with a Bruker 500 MHz spectrometer (Bruker-Biospin, Billerica, MA, USA) and values were given in ppm (*δ*). Column chromatography was carried out with macroporous resin (Diaion HP-20 and SP-700, Mitsubishi Chemical Corp, Tokyo, Japan) and Sephadex LH-20 (Pharmacia Fine Chemicals, Uppsala, Sweden). Flash chromatography was conducted using Combiflash RF200 (Teledyne Isco Corp, Nebraska, USA). Preparative HPLC was carried out on a Shimadzu LC-10A instrument with a SPD-20A detector (Shimadzu Corp, Tokyo, Japan), using YMC-Pack ODS-A column (250 mm×20 mm, 5 μm, YMC Corp, Kyoto, Japan). HPLC-DAD analysis was set up on Agilent 1200 series system (Agilent Technologies) with an Apollo C18 column (250 mm×4.6 mm, 5 μm, Alltech Corp, Kentucky, USA).

3.2. Plant material {#s0025}
-------------------

The root bark of the *L. chinense* was collected from Ningan Town, Zhongning County, Ningxia Hui autonomous region, People׳s Republic of China, in March 2012. A voucher specimen (ID-S-2592) was deposited in the Herbarium of the Institute of Materia Medica, Chinese Academy of Medical Science, Beijing.

3.3. Extraction and isolation {#s0030}
-----------------------------

The powdered plant material (100 kg) was extracted three times with 80% EtOH (600 L) under reflux. The solvent was evaporated and the crude residue (8.0 kg) was partitioned with EtOAc (3×45 L). The EtOAc and H~2~O solvent were removed under reduced pressure, which yielded Fr. 1 and Fr. 2, respectively. Fr. 1 (1.5 kg) was subjected to column chromatography on silica gel and continuously eluted with petroleum ether, EtOAc, acetone, and methanol, which gave fractions I--IV. Fraction II was further separated on silica gel chromatography column, and eluted with petroleum ether---EtOAc (from 100:0 to 0:100) in a gradient to afford 10 fractions (fractions II-1--II-10). Fr. II-2 was chromatographed over Sephadex LH-20 and eluted with gradient mixtures of MeOH\--H~2~O (from 60:40 to 100:0) to yield Fr. II-2-1--II-2-16. Fr. II-2--5 was further purified with pHPLC (MeOH-H~2~O, 65:35) to yield **8** (9 mg). Fr. II-6 was subjected to Combiflash RF200 apparatus with a C18 column (55 cm × 8 cm, 50 µm) and eluted with MeOH--H~2~O (from 5:95 to 100:0) to provide Fr. II-6-1--Fr. II-6-20. Compound **3** (20 mg) was obtained from Fr. II-6-12 by recrystallization. Fr. II-8 was purified using reversed-phase preparative HPLC with MeOH---H~2~O (60:40) as the mobile phase to give **4** (19 mg, min).

Fr. 2 (1.375 kg) was chromatographed with a macroporous resin column (HP-20, 200 cm×15 cm) and eluted successively with H~2~O, 15%, 30%, 50%, 70%, and 95% EtOH. The 30% EtOH fraction was concentrated and was further chromatographed over a macroporous resin (SP-700, 200 cm × 15 cm) and eluted successively with 15%, 20%, 25%, 30%, 45%, 50%, and 95% EtOH, which yielded fractions A--G. Fr. C (72 g) was subjected to Combiflash RF200 apparatus with a C18 column (55 cm × 8 cm, 50 µm) and eluted with MeOH--H~2~O (from 5:95 to 100:0) to provide Fr. C1--Fr. C25. Fr. C2 (4 g) was chromatographed over Sephadex LH-20 and eluted with gradient mixtures of MeOH---H~2~O (from 10:90 to 95:5) to yield Fr. C2-1--C2-19. Fr. C2-6 was purified with reverse-phase preparative HPLC (MeOH---H~2~O, 30:70) to yield **1** (20 mg) and **2** (35 mg). Fr. C6 was separated on Sephadex LH-20 column (H~2~O) and then further purified by reverse-phase preparative HPLC with MeOH--H~2~O (40:60) to afford **5** (13 mg), **6** (8 mg), and **7** (6 mg). Similar to Fr. C6, compound **9** (20 mg) was isolated from Fr. C8.

### 3.3.1. Lyciumlignan D (***1***) {#s0035}

White amorphous powder, \[*α*\]^20^~D~ + 22.9 (*c* 0.10 MeOH); UV (MeOH) *λ*~max~ (log*ε*): 238 (4.02), 282 (3.53) nm; CD (MeOH) *λ*~max~ (Δ*ε*): 217 (+5.03), 242 (+4.14), 286 (+0.89) nm; IR (KBr) *ν*~max~: 3382, 2929, 2881, 1616, 1518, 1463, 1332, 1217, 1114, 1068 cm^---1^; HR-ESI-MS: *m*/*z* 607.2000 \[M+Na\]^+^ (Calcd. for C~27~H~36~O~4~Na, 607.1997); For ^1^H NMR and ^13^C NMR spectroscopic data, see [Table 1](#t0005){ref-type="table"}.

### 3.3.2. Lyciumphenylpropanoid A (***2***) {#s0040}

White amorphous powder, IR (KBr) *ν*~max~: 3354, 2934, 1576, 1511, 1420, 1266, 1229, 1048, 859, 778 cm^---1^. HR-ESI-MS: *m*/*z* 571.2007 \[M+Na\]^+^ (Calcd. for C~24~H~36~O~14~Na, 571.1997). For ^1^H NMR and ^13^C NMR spectroscopic data, see [Table 1](#t0005){ref-type="table"}.

3.4. Determination of the absolute configuration of sugar {#s0045}
---------------------------------------------------------

Compounds **1** and **2** (2 mg) were separately dissolved in 1 mol/L CF~3~COOH---H~2~O (5 mL) and refluxed for 6 h. The mixture was concentrated under vacuum, and the residue was suspended in H~2~O and extracted three times with EtOAc. The aqueous layer was evaporated under vacuum, diluted repeatedly with H~2~O and evaporated under vacuum to produce a neutral residue. The residue was dissolved in fresh anhydrous pyridine (1.0 mL). [l]{.smallcaps}-Cysteine methyl ester hydrochloride (2 mg) was added, and the reaction mixture was incubated at 60 °C for 2 h. After that, *N*-trimethylsilylimidazole (0.2 mL) was added into the mixture which had been dried by nitrogen current. The reaction mixture was incubated at 60 °C for 2 h and partitioned between *n*-hexane and H~2~O (2 mL each). The *n*-hexane extract was subjected to GC analysis under the following conditions: capillary column, HP-5 (60 m×0.25 mm, with a 0.25 μm film, Dikma); Detection, FID; detector temperature, 300 °C; injection temperature, 300 °C; initial temperature 200 °C, then raised to 260 °C at 10 °C/min, final temperature maintained for 30 min; carrier, N~2~ gas. The [d]{.smallcaps}-apiose and [d]{.smallcaps}-glucose were confirmed by comparing the retention time of their derivatives to the standard sugar derivatized, which exhibited retention times of 18 and 29 min, respectively.

3.5. Anti-inflammatory effects of compounds {#s0050}
-------------------------------------------

Compounds **1**--**9** were tested for anti-inflammatory activity on BV2 microglial cells, using the same method as described in the Refs. [@bib22] and [@bib23].
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==================================
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